Altered translational repression of an RNA-binding protein, Elav by AOA2-causative Senataxin mutation

Area of Science:

• Molecular Biology
• Neurogenetics
• Drosophila melanogaster models

Background:

• Mutations in the Senataxin (SETX) gene are linked to Amyotrophic Lateral Sclerosis (ALS4) and Ataxia with Oculomotor Apraxia type 2 (AOA2).
• SETX is known to function at the intersection of transcription and DNA damage response pathways.
• The role of SETX in regulating RNA translation remains largely unexplored.

Purpose of the Study:

• To investigate whether the Senataxin (SETX) protein influences the translational control of specific RNAs.
• To explore the potential role of altered RNA translational repression in the pathogenesis of SETX-related neurological disorders.

Main Methods:

• Expression of a truncated, Ataxia with Oculomotor Apraxia type 2 (AOA2)-associated form of human Senataxin (SETX) in Drosophila neurons and muscles.
• Analysis of neuromuscular junction (NMJ) synapse development in Drosophila.
• Assessment of the translational repression of the RNA-binding protein Embryonic Lethal Abnormal Vision (Elav).

Main Results:

• Expression of truncated SETX in Drosophila neurons led to alterations in neuromuscular junction (NMJ) synapse development.
• Truncated SETX expression in Drosophila muscles resulted in dysregulated translational repression of the Elav RNA.
• Elav RNA, normally translationally repressed outside of neurons, showed altered repression patterns in the presence of mutant SETX.

Conclusions:

• Altered translational repression of RNA targets, such as Elav, by mutant Senataxin (SETX) may be a key mechanism in the pathology of ALS4 and AOA2.
• This study provides novel insights into the function of SETX beyond transcription and DNA repair, highlighting its role in post-transcriptional gene regulation.